In situ evidence of neoplastic cell phagocytosis by macrophages in papillary thyroid cancer

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 5, 1997, Pages 1615-1620

  Fiumara, Antonino ^a   Belfiore, Antonino ^a,b   Russo, Giovanna ^a   Salomone, Edvige ^a   Santonocito, Gabriella M ^a   Ippolito, Orazio ^a   Vigneri, Riccardo ^a   Gangemi, Pietro ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b Ist Med Int Malat Endocr M   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER GRADING; CANCER IMMUNOLOGY; FEMALE; HISTOPATHOLOGY; HOST RESISTANCE; HUMAN; IMMUNOPATHOGENESIS; LYMPHOCYTIC INFILTRATION; MACROPHAGE FUNCTION; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; PHAGOCYTOSIS; PRIORITY JOURNAL; THYROID PAPILLARY CARCINOMA;

EID: 0030918242     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.5.1615     Document Type: Article

References (28)

1. Underwood JCE. 1974 Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review. Br J Cancer. 30:538-548.
2. Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L. 1992 The origin and function of tumor-associated macrophages. Immunol Today. 13:265-270.
3. Baker J. 1995 The immune response to papillary thyroid cancer. J Clin Endocrinol Metab. 80:3419-3420.
4. Schroeder S, Schwarz W, Rehpenning W, Loning T, Bocker W. 1988 Dendritic/Langherans cells and prognosis in patients with papillary thyroid carcinomas. Immunocytochemical study of 106 thyroid neoplasms correlated to follow-up data. Am J Clin Pathol. 89:295-300.
5. Belfiore A. Mauerhoff T. Pujol-Borrell R, et al. 1991 De novo HLA class II and enhanced HLA class I molecule expression in SV-40 transfected human thyroid epithelial cells. J Autoimmun. 4:397-414.
6. Lucas-Martin A, Foz-Sala M, Todd I, Bottazzo GF, Pujol-Borrell R. 1988 Occurrence of thyrocyte HLA class II expression in a wide variety of thyroid disease: relationship with lymphocytic infiltration and thyroid autoantibodies. J Clin Endocrinol Metab. 66:367-75.
7. Tolosa E, Roura C, Marti E, Belfiore A, Pujol-Borrell R. 1992 Induction of ICAM-1 but not LFA-3 in thyroid follicular cells. J Autoimmun. 5:1019-1025.
8. Kaluza J. 1992 The monoclonal antibody (MAB) CD 68 allows the immunocytochemical identification of macrophages in primary and metastatic brain tumors in paraffin embedded tissues. Folia Histochem Cytobiol. 30:125-128.
9. Falini B, Flenghi L, Pileri S, et al. 1993 PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule. Am J Pathol. 142:1359-1372.
10. De Groot LJ, Kaplan EL, McCormick M, Strauss FH. 1990 Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab. 71:414-424.
11. Heidinger C, Williams ED, Sobin LH. 1988 World Health Organization histological typing of thyroid tumors, 2nd ed. Berlin: Springer-Verlag; 9-11.
12. Rosai J. 1993 Papillary carcinoma. Monogr Pathol. 35:138-165.
13. Pinkus GS, Kurtin PJ. 1985 Epithelial membrane antigen-a diagnostic discriminant in surgical pathology. Hum Pathol. 74:620-624.
14. Cox DR. 1972 Regression models and life-tables. J R Stat Soc B. 34:187-202.
15. Mazzaferri EL. 1993 Thyroid carcinoma: papillary and follicular. In: Mazzaferri L, Samaan NA, eds. Endocrine tumors. Cambridge: Blackwell; 278-333.
16. Boyd CK, Baker JR. 1996 The immunology of thyroid cancer. Endocrinol Metab Clin North Am. 25:159-179.
17. Bisi H, Fernandes VS, deCamargo RYA, Koch L, Abdo AH, deBrito T. 1989 The prevalence of unsuspected thyroid pathology in 300 sequential autopsies with special references to the incidental carcinoma. Cancer. 64:1888-1893.
18. Haapala AM, Soppi E, Morsky P, Salmi J, Laine S, Mattila J. 1994 Thyroid antibodies in association with thyroid malignancy. Simultaneous occurrence of thyroiditis and thyroid malignancy. APMIS. 102:390-394.
19. Juhasz F, Boros P, Szegedi G, et al. 1989 Immunogenetic and immunologic studies of differentiated thyroid cancer. Cancer. 63:1318-1326.
20. Allen CA, Hogg N. 1987 Association of colorectal tumor epithelium expressing HLA-D/DR with CD8 positive T-cells and mononuclear phagocytes. Cancer Res. 47:2919-2923.
21. + macrophages in antitumor cytotoxicity. Lab Invest. 67:166-174.
22. Factor SM, Biempica L, Ratner I, Ahuja KK, Biempica S. 1977 Carcinoma of the breast with multinucleated reactive stromal giant cells. Virchows Arch. 374:1-12.
23. Hashimoto H, Koga S, Watanabe H, Munetobe E. 1980 Undifferentiated carcinoma of the thyroid gland with osteoclast-like giant cells. Acta Pathol Jpn. 30:323-324.
24. Gaffey MJ, Lack EE, Christ ML, Weiss LM. 1991 Anaplastic thyroid carcinoma with osteoclast-like giant cells. A clinicopathologic, immunohistochemical and ultrastructural study. Am J Surg Pathol. 15:160-168.
25. Matsubayashi S, Kawai K, Matsumoto, et al. 1995 The correlation between papillary thyroid carcinoma and lymphocytic infiltration in the thyroid gland. J Clin Endocrinol Metab. 80:3421-3424.
26. Fidler IJ. 1985 Macrophages and metastases-a biological approach to cancer therapy: presidential address. Cancer Res. 45:4714-4726.
27. Belfiore A, Garofalo MR, Giuffrida D, et al. 1990 Increased aggressiveness of thyroid cancer in patients with Graves' disease. J Clin Endocrinol Metab. 70:830-835.
28. Farid NR, Shi Y, Zou M. 1994 Molecular basis of thyroid cancer. Endocr Rev. 15:202-232.